Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04958239
Title A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

pancreatic adenocarcinoma

skin melanoma

colorectal cancer

bladder urothelial carcinoma

stomach cancer

esophagus squamous cell carcinoma

lung non-small cell carcinoma

esophagus adenocarcinoma

malignant pleural mesothelioma

oral squamous cell carcinoma

cervical squamous cell carcinoma

ovarian carcinoma

Therapies

BI 754091 + BI 765179

BI 765179

Age Groups: adult | senior
Covered Countries USA | ESP | BEL


No variant requirements are available.